8-Weekly HIV Injections Outperform Daily Pills for Youth
Young people living with HIV achieve better viral suppression when receiving antiretroviral therapy via injections every eight weeks compared to daily tablets, according to clinical trial findings published in The Lancet and presented at the World AIDS Conference by UCL researchers. The LATA trial demonstrated that two-month long-acting cabotegravir and rilpivirine injections reduced viral rebound … Read more